-
'At home' Djokovic makes winning return in Athens
-
Manchester City have become 'more beatable', says Dortmund's Gross
-
Merino brace sends Arsenal past Slavia in Champions League
-
Djokovic makes winning return in Athens
-
Napoli and Eintracht Frankfurt in Champions League stalemate
-
Arsenal's Dowman becomes youngest-ever Champions League player
-
Cheney shaped US like no other VP. Until he didn't.
-
Pakistan edge South Africa in tense ODI finish in Faisalabad
-
Brazil's Lula urges less talk, more action at COP30 climate meet
-
Barca's Lewandowski says his season starting now after injury struggles
-
Burn urges Newcastle to show their ugly side in Bilbao clash
-
French pair released after 3-year Iran jail ordeal
-
EU scrambles to seal climate targets before COP30
-
Getty Images largely loses lawsuit against UK AI firm
-
Cement maker Lafarge on trial in France over jihadist funding
-
Sculpture of Trump strapped to a cross displayed in Switzerland
-
Pakistan's Rauf and Indian skipper Yadav punished over Asia Cup behaviour
-
Libbok welcomes 'healthy' Springboks fly-half competition
-
Reeling from earthquakes, Afghans fear coming winter
-
Ronaldo reveals emotional retirement will come 'soon'
-
Munich's surfers stunned after famed river wave vanishes
-
Iran commemorates storming of US embassy with missile replicas, fake coffins
-
Gauff sweeps Paolini aside to revitalise WTA Finals defence
-
Shein vows to cooperate with France in probe over childlike sex dolls
-
Young leftist Mamdani on track to win NY vote, shaking up US politics
-
US government shutdown ties record for longest in history
-
King Tut's collection displayed for first time at Egypt's grand museum
-
Typhoon flooding kills over 40, strands thousands in central Philippines
-
Trent mural defaced ahead of Liverpool return
-
Sabalenka to face Kyrgios in 'Battle of Sexes' on December 28
-
Experts call for global panel to tackle 'inequality crisis'
-
Backed by Brussels, Zelensky urges Orban to drop veto on EU bid
-
After ECHR ruling, Turkey opposition urges pro-Kurd leader's release
-
Stocks drop as tech rally fades
-
UK far-right activist Robinson cleared of terror offence over phone access
-
World on track to dangerous warming as emissions hit record high: UN
-
Nvidia, Deutsche Telekom unveil 1-bn-euro AI industrial hub
-
Which record? Haaland warns he can get even better
-
Football star David Beckham hails knighthood as 'proudest moment'
-
Laurent Mauvignier wins France's top literary award for family saga
-
Indian Sikh pilgrims enter Pakistan, first major crossing since May conflict
-
Former US vice president Dick Cheney dies at 84
-
Fiorentina sack Pioli after winless start in Serie A
-
Stocks drop as traders assess tech rally
-
Oscar-winning Palestinian films daily 'Israeli impunity' in West Bank
-
Spain's Telefonica shares drop on dividend cut, net loss
-
Fierce mountain storms kill nine in Nepal
-
Divisive Czech cardinal Dominik Duka dies at 82
-
Shein vows to cooperate with France in sex doll probe
-
EU in last-ditch push to seal climate targets before COP30
Japan firm probing 76 more deaths in supplement scare
Japanese health supplement maker Kobayashi Pharmaceutical said Friday it was probing 76 more deaths possibly linked to its tablets containing red yeast rice, meant to lower cholesterol.
It deepens a scandal that erupted earlier this year when the company said it was looking into five deaths potentially linked to the over-the-counter products after dozens of customers reported kidney problems.
Fermented with a mould culture, red yeast rice, or "beni koji", has been used in food, alcoholic drinks and folk medicines for centuries around East Asia.
"Even if the direct cause of hospitalisation or death was not kidney-related disease, it has become clear that there are a variety of cases, including cases in which beni koji-related products may have caused harm somehow and had some indirect impact," a Kobayashi statement said.
Of the five initial deaths under investigation, the company said it now knows one did not consume red yeast rice.
"We have received 1,656 inquiries from individuals who have sought medical attention, and have 76 cases under investigation over (a causal) connection to the deaths," in addition to the original four, it said.
On March 22, Kobayashi Pharmaceutical said it was recalling three kinds of tablets containing beni koji.
It later said it had detected a potentially toxic acid produced by the mould at one of its factories, and government officials inspected the firm's facilities.
Kobayashi Pharmaceutical is a household name in Japan, offering a wide range of health-related products, and the scandal has been top news in the country.
On Friday, Kobayashi said it would work to identify the exact cause and scope of the health damage -- including whether organs other than kidneys were harmed.
Top government spokesman Yoshimasa Hayashi said Friday that the health ministry had previously ordered the company to file a daily report on its probe, and demanded more details earlier this month after the number of deaths under investigation didn't change.
"But until today, it had not reported the specific number of cases under investigation, and it is extremely regrettable," Hayashi told reporters.
Kobayashi Pharmaceutical has said it also sold red yeast rice to around 50 other firms in Japan and two in Taiwan.
Taiwanese companies preventively recalled 154 products containing red yeast rice in the wake of the scare, the island's health authorities said earlier this year.
F.Qawasmeh--SF-PST